Active

MYRICX PHARMA LIMITED Financials

Company number
12082645Copy
copy info iconCopy
Registered office
2nd Floor, The Westworks Building White City Place, 195 Wood Lane, London W12 7FQ
Incorporated
03/07/2019

Company snapshot

Status
Active
Employees
8 (2023)
Latest financial data
2023
Accounts type
Small

Financial highlights

Latest reported figures. Okredo holds filed data for 2021–2023.

Net Assets

£-3.68M2023
-208.33%vs 2022

2022: £-1.20M

Total Assets

£1.69M2023
-27.39%vs 2022

2022: £2.32M

Cash in Bank

£985.11K2023
-35.48%vs 2022

2022: £1.53M

Total Liabilities

£5.33M2023
54.14%vs 2022

2022: £3.45M

Employees

82023
+2vs 2022

2022: 6

In 2023, MYRICX PHARMA LIMITED reported net assets of £-3.68M. The same filing shows total assets of £1.69M, cash in bank of £985.11K and total liabilities of £5.33M. Reported headcount was 8 in 2023. Net Assets fell from £-1.20M in 2022 to £-3.68M in 2023 (-208.33%). Okredo holds filed figures for 2021–2023; the table below lists every reported indicator by year. See every reported indicator by year.

Financial performance

Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.

Net Assets

£-3.68M2023
-208.33%from £-1.20M in 2022

Year-on-year change

Net Assets as filed for 2021–2023. Every figure in this chart is also in the financial history table.

3-year financial trend (2021–2023)

How the figures MYRICX PHARMA LIMITED filed moved across the three reported years 2021, 2022 and 2023 — measured end to end rather than year on year.

Net Assets

£1.42M2021£-3.68M2023
-360%vs 2021

Cash in Bank

£884.57K2021£985.11K2023
+11.4%vs 2021

+5.5% a year compound (CAGR)

Total Assets

£1.65M2021£1.69M2023
+2%vs 2021

+1% a year compound (CAGR)

Total Liabilities

£157.07K2021£5.33M2023
+3290%vs 2021

+482% a year compound (CAGR)

Employees

5202182023
+60%vs 2021+3

Biggest increase

Total Liabilities+3290%

£157.07K in 2021 to £5.33M in 2023

Biggest decrease

Net Assets-360%

£1.42M in 2021 to £-3.68M in 2023

MYRICX PHARMA LIMITED's filings pull in both directions between 2021 and 2023. The steepest rise came in total liabilities, pointing to heavier outstanding obligations, set against a fall in net assets, pointing to a weakening balance sheet. See the full year-by-year figures.

Ratios from the filed figures

Calculated from MYRICX PHARMA LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.

Net assets to total assets
-218.34%2023

Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.

Liabilities to total assets
315.53%2023

Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.

Cash to liabilities
18.50%2023

Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.

Cash to total assets
58.37%2023

Reported cash in bank divided by reported total assets, for the latest year both were filed.

Financial history

Every indicator Okredo tracks, year by year.

Reported financial indicators for MYRICX PHARMA LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.

Indicator202120222023
Net Assets£1.42M-1.20M-3.68M
Total Assets£1.65M2.32M1.69M
Cash in Bank£884.57K1.53M985.11K
Total Liabilities£157.07K3.45M5.33M
Employees568

MYRICX PHARMA LIMITED financials: frequently asked questions

Answered from this company's own filed figures.

Has MYRICX PHARMA LIMITED filed financial statements?

toggle

Yes. Okredo holds filed figures for MYRICX PHARMA LIMITED covering 2021–2023, across 5 reported indicators. The most recent reported year is 2023.

What net assets did MYRICX PHARMA LIMITED report in 2023?

toggle

MYRICX PHARMA LIMITED reported net assets of £-3.68M for 2023. That compares with £-1.20M in 2022, a change of -208.33%.

What total assets did MYRICX PHARMA LIMITED report in 2023?

toggle

MYRICX PHARMA LIMITED reported total assets of £1.69M for 2023. That compares with £2.32M in 2022, a change of -27.39%.

What cash in bank did MYRICX PHARMA LIMITED report in 2023?

toggle

MYRICX PHARMA LIMITED reported cash in bank of £985.11K for 2023. That compares with £1.53M in 2022, a change of -35.48%.

How many people does MYRICX PHARMA LIMITED employ?

toggle

MYRICX PHARMA LIMITED reported 8 employees in 2023, compared with 6 in 2022.

How have MYRICX PHARMA LIMITED financials changed over the last 3 years?

toggle

Between 2021 and 2023, MYRICX PHARMA LIMITED's net assets fell by 360%, cash in bank rose by 11.4%, total assets rose by 2% and total liabilities rose by 3290%. Cash in bank compounded at 5.5% a year across the two years to 2023, from £884.57K to £985.11K. Reported headcount went from 5 in 2021 to 8 in 2023 (+3).

Which years of MYRICX PHARMA LIMITED financial data are available?

toggle

Okredo holds reported figures for the years 2021, 2022, 2023. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.